The EudraCT number has been issued

On 30th August 2022 BioHealing obtained the EudraCT number 2022-002991-35 for the study Freeze-dried amniotic membrane in the treatment of non-healing wounds: a single-arm, retrospectively-prospective clinical trial. The study will be conducted in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice (ICH E6) and all applicable regulatory requirements.

We handle your personal data (name and e-mail address) in accordance with GDPR. We only process these data for the purpose of communicating with you, for the absolutely-required length of time. You may withdraw your consent to the processing of these data at any time at


Our company constatly seeks out new candidates, who could enrich our fast paced biotechnological company with their knowledge and know-how.

If you have a relevant education background and expertise in the following pharmaceutical industry, biotech, healthcare and are interested to become part of innovative projects in the area of development and manufacturing of products derived from perinatal tissues, dont hesitate to contact us.

Please send us your CV and cover letter to